BACKGROUND: Nicorandil, an adenosine triphosphate-sensitive potassium channel opener, is reported to have an antinociceptive effect by hyperpolarization through the K ϩ channel. The activation of extracellular signal-regulated kinase (ERK), a family of mitogen-activated protein kinases, plays an important role in synaptic plasticity and noxious stimulation in the dorsal root ganglion, and spinal neurons have been reported to induce its activation. To understand the biological mechanisms of nicorandil, we examined the effects of nicorandil on muscarinic acetylcholine (ACh) receptor-mediated activation of ERK in a neuronal model cell, rat pheochromocytoma PC12 cells. METHODS: PC12 cells were stimulated with ACh in the presence or absence of nicorandil, and phosphorylation of ERK was examined by a Western blot analysis. We also examined the effects of nicorandil on the ERK activation induced by 4␤-phorbol 12-myristate 13-acetate, an activator of protein kinase C, or ionomycin, a calcium ionophore. Intracellular Ca 2ϩ increase was visualized in fluo-3-loaded PC12 cells using fluorescence microscopy. RESULTS: Nicorandil inhibited ACh-induced ERK activation in a concentrationdependent manner. The inhibition was abolished by glibenclamide, an adenosine triphosphate-sensitive potassium channel blocker. Nicorandil suppressed the ERK activation induced by ionomycin but not 4␤-phorbol 12-myristate 13-acetate. Pretreatment of PC12 cells with nicorandil reduced the intracellular Ca 2ϩ concentration stimulated by ACh. CONCLUSIONS: Nicorandil inhibits muscarinic activation of the ERK signaling pathway by reducing the intracellular Ca 2ϩ concentration.
BACKGROUND: Nicorandil, an adenosine triphosphate-sensitive potassium channel opener, is reported to have an antinociceptive effect by hyperpolarization through the K ϩ channel. The activation of extracellular signal-regulated kinase (ERK), a family of mitogen-activated protein kinases, plays an important role in synaptic plasticity and noxious stimulation in the dorsal root ganglion, and spinal neurons have been reported to induce its activation. To understand the biological mechanisms of nicorandil, we examined the effects of nicorandil on muscarinic acetylcholine (ACh) receptor-mediated activation of ERK in a neuronal model cell, rat pheochromocytoma PC12 cells. METHODS: PC12 cells were stimulated with ACh in the presence or absence of nicorandil, and phosphorylation of ERK was examined by a Western blot analysis. We also examined the effects of nicorandil on the ERK activation induced by 4␤-phorbol 12-myristate 13-acetate, an activator of protein kinase C, or ionomycin, a calcium ionophore. Intracellular Ca 2ϩ increase was visualized in fluo-3-loaded PC12 cells using fluorescence microscopy. RESULTS: Nicorandil inhibited ACh-induced ERK activation in a concentrationdependent manner. The inhibition was abolished by glibenclamide, an adenosine triphosphate-sensitive potassium channel blocker. Nicorandil suppressed the ERK activation induced by ionomycin but not 4␤-phorbol 12-myristate 13-acetate. Pretreatment of PC12 cells with nicorandil reduced the intracellular Ca 2ϩ concentration stimulated by ACh. CONCLUSIONS: Nicorandil inhibits muscarinic activation of the ERK signaling pathway by reducing the intracellular Ca 2ϩ concentration. Ni corandil is an adenosine triphosphate sensitive potassium (K ϩ ATP ) channel opener. Previous studies demonstrate that the opening of central K ϩ ATP channels may elicit the antinociceptive effect, 1 and enhance the analgesic action of morphine and dexmedetomidine. 2 The K ϩ ATP channel openers induce cell hyperpolarization, thus, resulting in a decrease in the intracellular calcium ion (Ca 2ϩ ) level and neurotransmitter release (calcitonin gene-related peptide and substance P) which account for antinociception. 3, 4 However, the mechanism involving intracellular signal transduction underlying the antinociception in neurons is not yet clearly understood.
The mitogen-activated protein kinase (MAPK) is a family of serine or threonine protein kinases that transduce extracellular stimuli into intracellular posttranslational and transcriptional responses. [5] [6] [7] The MAPK family includes extracellular signal-regulated kinase (ERK), p38 MAPK, c-Jun N-terminal kinase/stressactivated protein kinase and ERK5. The activation of ERK by MAP kinase (MEK) 8 is involved in neuronal plasticity, such as long-term enhancement, 9 long-term facilitation, 10 and long-term spatial memory. 11, 12 In addition, the phosphorylation of ERK in primary afferent neurons occurs after noxious stimulation, and a MEK inhibitor U0126 dose-dependently attenuates thermal hyperalgesia after capsaicin injection. 13 These studies suggest that the intracellular signal transduction pathway involving ERK activation in neurons may therefore play a crucial role in pain hypersensitivity.
Rat pheochromocytoma (PC12) cells contain Na ϩ , K ϩ , and Ca 2ϩ channels and several membrane-bound receptors, including muscarinic (mAChR) and nicotinic acetylcholine (ACh) receptors. 14 They exhibit a number of properties characteristic of sympathetic neurons, 15 and have been used widely to investigate signal transduction and are often used as a model system of neuronal proliferation and differentiation. We previously studied and described the inhibitory effect of local anesthetics on muscarinic receptormediated activation of ERK by using PC12 cells. 16 mAChR are widely distributed in the peripheral and central nervous systems. They play a role in motor function and the processing of sensory information in the human spinal cord 17 and activate many downstream signaling pathways, including the ERK activating pathway. 18 Therefore, to examine whether the K ϩ ATP channel opener elucidates some of the mechanisms, including the intracellular ERK activation pathway, we investigated the effect of nicorandil on mAChR-mediated ERK activation using the PC12 cells as a neuronal model.
METHODS
Nicorandil and glibenclamide were purchased from Wako Pure Chemical Industries (Osaka, Japan). ACh, atropine sulfate salt, and 4␤-phorbol 12-myristate 13-acetate (PMA) were from Nacalai Tesque (Kyoto, Japan). Ionomycin was purchased from Calbiochem (Nottingham, UK). Fluo-3 AM, albumin, Dullbecco modified Eagle's medium (DMEM) were purchased from Sigma Chemical Company (St. Louis, MO). Rabbit polyclonal antibodies against Tyr 204 phosphorylated ERK1/2 (p-ERK1/2) and ERK1/2 (total-ERK1/2) were from Cell Signaling Technology (Danvers, MA). Anti-rabbit immunoglobulin G horseradish peroxidase linked whole antibody (from donkey) was purchased from Amersham Bioscience (Buckinghamshire, UK). The Western blot analysis was performed using the ECL Western Blotting Detection System (GE Healthcare Bio-Sciences Corp., NJ).
PC12 cells were a kind gift of Dr. Y. Sugimoto (Shirakawa Institute of Animal Genetics, Fukushima, Japan). Monolayer cultures of the cells were maintained in 100-mm-diameter tissue culture dishes in DMEM supplemented with 10% (vol/vol) fetal bovine serum and 5% (vol/vol) horse serum in a humidified atmosphere containing 5% carbon dioxide at 37°C. The stock cultures were subcultured routinely at a cell density of 2-3 ϫ 10 6 /dish at least once a week, and the culture media were renewed every 2 d.
PC12 cells were subcultured in 60-mm-diameter tissue culture dishes at 8 ϫ 10 5 cells/dish and grown for 3 d. The cells were washed twice with 2 mL buffer A (1 mM CaCl 2 , 1 mM MgCl 2 , 1 mg/mL albumin, 5 mM glucose in Hanks' Balanced Salt Solutions) and preincubated in 3 mL buffer A with or without nicorandil or atropine at 37°C for 10 min. The cells were stimulated with 0.1 mM ACh for 2 min, 100 nM PMA for 5 min, 100 nM ionomycin for 15 min, or 10 mM NaF plus 10 M AlCl 3 for 30 min at 37°C. The reaction was terminated by aspiration of the reaction buffer and washed twice with 2 mL ice-cold phosphate-buffered saline. The washed cells were scraped quickly into 100 L RIPA buffer (10 mM Tris-HCl, pH 7.4, 0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate, 150 mM NaCl, 1% NP-40), and lysed by two freeze-thaw cycles. The cell suspension was then centrifuged at 1500 rpm for 5 min to obtain the cell extract. The soluble extract (20 g of protein of each sample) was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10%) and electrophoretically transferred to a polyvinylidene difluoride membrane. After the membranes were blocked with TBS-T (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1% Tween-20) containing 2% albumin, membranes were probed with antibodies against phospho-specific or total -ERK1/2 (1:2000) for 90 min at room temperature and then with the donkey Antirabbit immunoglobulin G horseradish peroxidase linked whole antibody for 60 min at room temperature. The bound antibodies were detected using the ECL Western blotting detection system. The density of protein bands was analyzed using a densitometer (Densitograph; Atto Corporation, Tokyo, Japan).
To visualize the increase in the intracellular Ca The data are presented as the mean Ϯ sd from three different experiments and three determinant analyses. The bands were quantified by scanning densitometry and the ratio of phosphorylated ERK to total ERK was calculated. The differences between the values were evaluated by Student's t-test. The results were considered statistically significant when P Ͻ 0.05.
RESULTS

Muscarinic Receptor Stimulation Induces ERK Phosphorylation in PC12 Cells
Treatment of PC12 cells with 0.1 mM ACh-induced rapid and transient increases in ERK1/2 phosphorylation as examined by a Western blot analysis with phospho-specific antibody against pERK1/2. The phosphorylation of ERK1/2 increased at a peak 2 min after stimulation with ACh and decreased to the basal level 10 min after stimulation (Fig. 1) . The AChinduced ERK1/2 activation was increased approximately nine times in comparison to the level without ACh stimulation. To determine if the ACh-mediated phosphorylation of ERK was due to mAChR activation, we examined the effect of pretreatment with the muscarinic-specific antagonist atropine on the ERK activation. The pretreatment of the cells with 5 M atropine for 10 min completely abolished the ACh-induced increase of ERK1/2 phosphorylation (Fig. 2) , suggesting that the ACh-induced ERK activation was mediated via mAChR.
Nicorandil Inhibits ACh-Induced ERK Phosphorylation in PC12 Cells
To examine the effect of nicorandil on AChinduced ERK activation, PC12 cells were pretreated with 0.1-10 mM nicorandil for 10 min. As shown in Figure 3 , the treatment with nicorandil inhibited AChinduced ERK1/2 phosphorylation in a concentrationdependent manner, and it was completely abolished at 10 mM (Fig. 3) .
Nicorandil is a vasodilator with the dual properties of a K ϩ ATP channel opener and a nitrate generator. The bands were quantified by scanning densitometry and the ratio of phosphorylated ERK to total ERK was calculated. The data were expressed as percent of the expression ratio regarding without nicorandil as 100%. The values represent the mean Ϯ sd for three different experiments and P Ͻ 0.05 was considered significant in comparison to the control. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 versus the control.
Effects of Nicorandil on ERK Phosphorylation Caused by PMA and Ionomycin
The combination of NaF plus AlCl 3 
Effect on PMA-Induced ERK Phosphorylation
Our previous study demonstrated that PMA, an activator of PKC which is often used as a receptor-bypass stimuli, causes the activation of ERK1/2 in PC12 cells. 16 We thereafter examined whether nicorandil exerts an inhibitory effect on PMA-induced ERK phosphorylation. The treatment with 10 mM nicorandil did not have any effect on PMA-induced ERK1/2 phosphorylation (Fig. 4) .
Effect on Ionomycin-Induced ERK Phosphorylation
Ca 2ϩ is one of the second messengers of the MAPK pathway, and activation of mAChR causes the rapid release of Ca 2ϩ from intracellular stores and a sustained influx of external Ca 2ϩ in PC12 cells. 21, 22 In this relation, we examined whether nicorandil has an effect on ERK activation by an increase of the influx of Ca 2ϩ using calcium ionophore ionomycin. As shown in Figure 5 , ionomycin (100 nM) induced ERK1/2 phosphorylation at 80% of ACh stimulation in PC12 cells, and the pretreatment with 10 mM nicorandil inhibited ionomycin-induced ERK1/2 phosphorylation by approximately 60%. This result suggests that nicorandil partially inhibits Ca 2ϩ -induced ERK1/2 phosphorylation in PC12 cells.
Nicorandil Suppresses the Increase of Intracellular Ca
2؉
Concentration
We then examined the effect of nicorandil on the ACh-induced increase of intracellular Ca 2ϩ concentration. The increase of intracellular Ca 2ϩ concentration was measured by visualizing, using fluorescence microscopy, PC12 cells pretreated with or without 10 mM nicorandil before 0.1 mM ACh stimulation. As shown in Figure 6 , ACh stimulation induced many luminous cells in comparison to the control cells. In the nicorandil-treated cells, only few luminous cells were observed. This result suggests that nicorandil inhibits the ACh-induced increase of intracellular Ca 2ϩ concentration.
DISCUSSION
The present study demonstrated that nicorandil suppressed mAChR-mediated ERK phosphorylation Previous studies suggest that the mAChR stimulation increases the intracellular Ca 2ϩ concentration by 1) redistribution of Ca 2ϩ from cytoplasmic stores to the cytosol, mediated by generation of inositol 1,4,5-triphosphate (IP 3 ) as a consequence of the muscarinicreceptor-coupled hydrolysis of phosphatidylinositol 4,5-bisphosphate and 2) increased Ca 2ϩ influx through a pathway of the plasma membrane. 22 In addition, it has also been well documented that the 3) emptying of intracellular Ca 2ϩ stores often stimulates the influx of extracellular Ca 2ϩ . 21 Nicorandil causes the cell membrane hyperpolarization induced by K ϩ ATP channel opener to inhibit Ca 2ϩ influx by blocking voltagedependent Ca 2ϩ channels 23 and Ca 2ϩ release from intracellular stores by IP 3 production. 24 In the rat myocytes, nicorandil attenuates the mitochondrial Ca 2ϩ overload induced by depolarization of the mitochondrial membrane. 25 These results suggest that nicorandil suppresses the intracellular Ca 2ϩ concentration. In our study, we demonstrated that nicorandil partially inhibited the ionomycin-induced ERK phosphorylation, suggesting that nicorandil may abolish the increase of intracellular Ca 2ϩ concentration, by not only the cell hyperpolarization, but also by inhibiting the redistribution of Ca 2ϩ from the cytoplasmic stores to the cytosol and/or the inhibition of the following Ca 2ϩ influx via activation of Ca 2ϩ store-operated channels. There are five mAChR subtypes, m1ϳm5, which classically couple to 2 G proteins, Gi and Gq. As summarized in Figure 7 , MAPK has been shown to be activated via Gq-coupled receptor m1 in PC12 cells. 18 When the mAChRs are stimulated, the ␣ subunit of Gq dissociated from the ␤␥ subunits stimulates phospholipase C activation. Phospholipase C activation, in turn, hydrolyzes phosphatidylinositol 4,5-bisphosphate into IP 3 and diacylglycerol, both of which activate PKC. PKC could be involved in the ERK activation by Raf phosphorylation on serine residues and initiates a sequence of activation of Ras, Raf and MEK that, in turn, activates ERK. 16 IP 3 redistributes Ca 2ϩ from intracellular stores to the cytosol, and free cytosolic Ca 2ϩ activate Ca 2ϩ -dependent tyrosine kinase 2 (Pyk2). Pyk2, together with src, has been shown to recruit Grb2-SOS to the plasma membrane and in this way induces Ras activation. 26 PMA-induced ERK phosphorylation was not affected by the presence of nicorandil. This led us to the conclusion that nicorandil inhibits muscarinic activation of ERK via the action on the upstream of PKC or independent of PKC at the target sites.
The intracellular signal transduction pathways in neurons after noxious stimulation are not well understood. However, several studies have reported ERK phosphorylation to occur in dorsal root ganglion neurons and dorsal horn neurons in response to noxious stimuli of the peripheral tissue or electrical stimulation to the peripheral nerve, i.e., activitydependent activation of ERK in nociceptive neurons. 13, 27, 28 Under conditions of tissue and nerve damage, ERK can be activated by nociceptive activity and inflammatory mediators in primary sensory neurons in the peripheral nervous system, and spinal cord neurons and glia in the central nervous system. 29 The activation of ERK in the peripheral and central nervous systems is nociceptive-specific and suppressed by several analgesics. Therefore, examination of ERK activation has potential for the development of an assay to test the efficacy of new analgesics.
Asano et al. 2 reported the epidural administration of K ϩ ATP channel openers (levcromakalim and nicorandil) to enhance the analgesic action of both morphine and dexmedetomidine, probably via the activation of K ϩ ATP channels and modified morphine's pharmacokinetics at the spinal cord level, and that they could modulate the activities of intracellular second messengers, such as Ca 2ϩ . Because another study suggested that K ϩ ATP channel-opening plays a role in capsaicinevoked acute nociception mechanisms, 30 the K ϩ ATP channel opener may therefore modulate Ca 2ϩ influx. We therefore examined whether -opioid and ␣ 2 -agonists have any effect on the ERK phosphorylation and K ϩ ATP channel opener to modify the effect of -opioid and ␣ 2 -agonists in PC12 cells. In addition, it was also thus considered worthwhile to examine the effect of K ϩ ATP channel opener on the ERK phosphorylation in the dorsal root ganglion neurons or dorsal horn neurons under conditions of tissue and nerve damage based on the present findings.
In conclusion, a K ϩ ATP channel opener nicorandil inhibits the mAChR-mediated activation of ERK, which is implicated in the suppression of the increase of intracellular Ca 2ϩ concentration in PC12 cells.
